EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate, and when can generic versions of Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate launch?
Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate is a drug marketed by Aurobindo Pharma Ltd, Laurus, and Macleods Pharms Ltd. and is included in four NDAs.
The generic ingredient in EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE is efavirenz; lamivudine; tenofovir disoproxil fumarate. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the efavirenz; lamivudine; tenofovir disoproxil fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?
- What are the global sales for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?
- What is Average Wholesale Price for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?
Summary for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 28 |
| DailyMed Link: | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE at DailyMed |
Recent Clinical Trials for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | N/A |
| Professor Francois Venter | Phase 3 |
| Yu-Jay Corp. | Phase 3 |
See all EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE clinical trials
Pharmacology for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
US Patents and Regulatory Information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | efavirenz; lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 022343-001 | Aug 15, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Macleods Pharms Ltd | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | efavirenz; lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 210649-001 | Mar 15, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Laurus | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | efavirenz; lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 213038-001 | May 14, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
